Discover how 3D organoids are already shaping research & drug development today and explore their future potential Dive into our report and… More about this report: The market for advanced cell models is booming and expected to grow from $1.42 billion in 2022 to $5.29 billion by 2032. This surge is driven by the unique […]
Epic Bio is an epigenetic editing company, leveraging the power of CRISPR without cutting DNA. The company’s proprietary Gene Expression Modulation System (GEMS) includes the smallest Cas protein known to work in human cells. This enables in vivo or ex vivo delivery via a single viral vector. Epic’s lead program, EPI-321, is in IND-enabling studies […]